Ascendis Pharma A (ASND)
Ascendis Pharma A (ASND) is a Healthcare stock tracked by StreetAlpha. ASND reports earnings on Wed, Nov 11, 2026. The average 12-month price target from 13 analysts is $314.00, with a high of $344.00 and a low of $273.00. Analyst consensus is Strong Buy, based on the latest ratings from 13 firms (13 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in ASND, 0% of them bullish and 100% bearish. In the past 30 days there were 10 dark pool prints totaling $12.5M, the largest $3.3M.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 13 analysts who set a price target on ASND in the past 90 days. The average target is $314.00, with a high of $344.00 and a low of $273.00.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 28 | Cantor Fitzgerald | Reiterated | Buy | $300 |
| Sep 15 | Raymond James | Downgrade | Buy | $287 |
| Sep 2 | Oppenheimer | Maintained | Buy | $312 |
| Sep 1 | Morgan Stanley | Target lowered | Buy | $275 → $273 |
| Sep 1 | Wedbush | Reiterated | Buy | $327 |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ASND is in one of them and how their past ASND trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered ASND in an article yet. Here's the latest on the wider market.
For informational purposes only. Not financial advice. Options flow and dark pool data are delayed and may be incomplete.